Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: Antibiotic Prophylaxis for Neurogenic Bladder Botox [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating antibiotic prophylaxis to prevent postoperative urinary tract infections in patients treated with Botox for neurogenic bl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antibiotic prophylaxis
  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of Alberta | Conditions: Neurogenic Bladder, Post-operative Urinary Tract Infections | Phase 2 | Status: RECRUITING